FINWIRES · TerminalLIVE
FINWIRES

Ciena Expects Continued Market Share Gains Driven by Technology Lead, Morgan Stanley Says

By

Ciena (CIEN) expects to continue gaining market share as indicated by its updated targets, including a roughly 30% compound annual growth rate for revenue over the next three years, Morgan Stanley said in a Thursday note.

The company has built its technology lead over the last 10 years, with a market share growth of 1,100 basis points in the last four years excluding China, the investment firm noted. At a recent event, Ciena highlighted its potential for further growth, backed by their products' competitive advantage and new markets, according to the note.

Ciena estimates $12 billion in new market opportunities in data center by 2029, potentially increasing its total addressable market, Morgan Stanley said. The company is also working to mitigate supply constraints for key components by qualifying other suppliers and securing long-term deals, the brokerage added.

Morgan Stanley maintained its equal-weight rating on Ciena, with a higher price target of $450 from $425.

Price: $357.36, Change: $+16.86, Percent Change: +4.95%

What else is happening in Wire?

Wire

Halozyme Therapeutics Plans $1.05 Billion Offering of Convertible Notes

Halozyme Therapeutics (HALO) plans to launch an offering of $1.05 billion of convertible senior notes due 2033, subject to market conditions.Initial purchasers will have a 13-day option to buy up to an additional $150 million of the notes, the company said Wednesday in a statement.Halozyme expects to use part of the proceeds to fund capped call transactions and to enter agreements with holders of its 0.25% convertible notes due 2027 and 1% convertible notes due 2028 to repurchase their notes for cash. The remainder will be used for general corporate purposes.Halozyme shares fell 1.8% in after-hours trading.

$HALO
Wire

Medical Properties Trust Completes Sale of 2 Idaho Hospitals

Medical Properties Trust (MPT) completed the sale of two Idaho hospital properties to affiliates of Intermountain Health for $413 million.The company said Wednesday it received $371 million in cash proceeds for Idaho Falls Community Hospital and Mountain View Hospital with $42 million distributed to minority real-estate owners.The sale represents a gain of about $130 million over the hospitals' gross book value, Medical Properties Trust said.The company expects to use a majority of the proceeds to reduce debt.Medical Properties Trust shares rose 2.1% in after-hours trading.

$MPT
Wire

BCB Bancorp Launches Stock Offering; Identifies Portfolio of Problem Loans; Expects Q3 Net Loss

BCB Bancorp (BCBP) said Wednesday it has launched an underwritten public offering of shares. Net proceeds will be used for general corporate purposes and to support capital, including in connection with the planned disposition of potential problem loans, among other purposes, it said.The company said that the management of its unit BCB Community Bank has identified for sale and started marketing of a portfolio of problem loans.The bank has received indications of interest from potential buyers covering all of the about $210 million principal balance of the problem loans for sale, it said, adding it expects to complete the sales during Q3.In addition, the bank said that during Q3, it plans to transfer about $27 million of commercial real estate loans showing credit weakness to held for sale. The bank also said it started marketing for the potential sale of its business lines focused on cannabis-related clients.The company said it now expects a Q3 provision for credit losses of $112 million to $120 million, and to post a Q3 net loss between $126.2 million and $136.1 million.BCB Bancorp shares were down nearly 8% in after-hours activity.

$BCBP